Acorn Capital Advisors as of June 30, 2025
Portfolio Holdings for Acorn Capital Advisors
Acorn Capital Advisors holds 21 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology (CGON) | 19.2 | $29M | 1.1M | 26.00 | |
| Urogen Pharma (URGN) | 11.3 | $17M | 1.3M | 13.70 | |
| Y Mabs Therapeutics | 10.1 | $15M | 3.4M | 4.51 | |
| Puma Biotechnology (PBYI) | 9.3 | $14M | 4.1M | 3.43 | |
| Candel Therapeutics (CADL) | 8.5 | $13M | 2.6M | 5.06 | |
| Trevi Therapeutics (TRVI) | 7.7 | $12M | 2.1M | 5.47 | |
| Terns Pharmaceuticals (TERN) | 4.8 | $7.4M | 2.0M | 3.73 | |
| Onkure Therapeutics Class A Com (OKUR) | 4.4 | $6.8M | 2.8M | 2.39 | |
| Cybin Com New (CYBN) | 4.0 | $6.2M | 734k | 8.39 | |
| Bicara Therapeutics (BCAX) | 3.9 | $6.0M | 643k | 9.29 | |
| Protara Therapeutics Com Stk (TARA) | 3.5 | $5.3M | 1.8M | 3.03 | |
| Cardiff Oncology (CRDF) | 2.9 | $4.4M | 1.4M | 3.15 | |
| Aura Biosciences (AURA) | 2.4 | $3.7M | 596k | 6.26 | |
| Verastem (VSTM) | 2.1 | $3.2M | 780k | 4.15 | |
| Aadi Bioscience (WHWK) | 1.4 | $2.1M | 1.1M | 1.87 | |
| Bioatla (BCAB) | 1.3 | $1.9M | 4.8M | 0.40 | |
| Mural Oncology (MURA) | 1.1 | $1.6M | 654k | 2.47 | |
| Vyne Therapeutics (VYNE) | 0.8 | $1.2M | 737k | 1.65 | |
| Q32 Bio (QTTB) | 0.8 | $1.2M | 803k | 1.49 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.3 | $482k | 405k | 1.19 | |
| X4 Pharmaceuticals | 0.2 | $292k | 154k | 1.90 |
